Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "ST Pharm"
Home
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug application for its dual-antibody...
03/04/2026, 01:23 ET
"K-Health Content for 4.7 Billion People": Kormedi.com Launches Global Multilingual Service
Kormedi.com, South Korea’s premier health and medical media outlet, is officially going global. On March 3, the company launched its multilingual...
03/04/2026, 01:22 ET
SK Bioscience Secures First EU-Led Vaccine Project in Landmark Triple Consortium
SK Bioscience announced on February 26th that a tripartite consortium including the company has been selected for the...
03/02/2026, 03:18 ET
Is Your 'Focus Supplement' a Warning Sign? High Tyrosine Levels Linked to Shorter Lifespan in Men
Tyrosine, an amino acid widely marketed as a cognitive enhancer to sharpen focus, may be linked to a significant...
03/02/2026, 03:18 ET
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple...
03/01/2026, 03:19 ET
VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?
VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
02/28/2026, 20:17 ET
Forget the Pharmacy: Why the ‘Rainbow Diet’ Trumps Antioxidant Pills
In large-scale studies conducted by U.S. national institutions and Harvard Medical School—such as the ATBC, CARET,...
02/27/2026, 03:45 ET
U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?
As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market...
02/22/2026, 22:50 ET
Zinc for Immunity: Why Long-Term Use Can Trigger Nerve Damage
When it comes to supplements, the "more is better" philosophy can be dangerous. Zinc is widely celebrated as an...
02/18/2026, 04:52 ET
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
02/18/2026, 04:26 ET
Previous
22
23
24
25
26
Next